22297 Hamburg, de
+49 (40) 5555090-3051
Senvion decides not to pursue private placement
As the offering is secondary in nature, the decision does not affect the growth strategy of Senvion focused on expanding into new markets and the strong momentum the company is experiencing.
Information and Explanation of the Issuer to this News:
Certain statements in this ad hoc release are forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. No one undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. You should not place any undue reliance on forward-looking statements which speak only as of the date of this press release. Statements contained in this ad hoc release regarding past trends or events should not be taken as representation that such trends or events will continue in the future. The cautionary statements set out above should be considered in connection with any subsequent written or oral forward-looking statements that Senvion S.A. (the 'Company'), or persons acting on its behalf, may issue.
This ad hoc release does not constitute an offer of securities for sale or a solicitation of an offer to purchase securities. The securities referred to in this ad hoc release have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the 'Securities Act'), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.